COMP <GO>
AZZ vs TMO // FORWARD P/E MULTIPLE
AZZ Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: AZZ 7
— TMO 4
▲ FORWARD P/E MULTIPLE LEADER: AZZ
LAST: $138.02 (+0.82%) • MKT CAP: $4.13B
forward-pe
12.1x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AZZ VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AZZ | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.30% | 9.30% | +2.00 | AZZ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.0x | 30.4x | -16.40 | AZZ | /valuation <GO> |
| Free Cash Flow Yield | 10.77% | 2.40% | +8.37 | AZZ | /fcf-yield <GO> |
| Operating Margin | 16.00% | 17.40% | -1.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 19.20% | 15.10% | +4.10 | AZZ | /net-margins <GO> |
| Revenue Growth (YoY) | 4.60% | 3.90% | +0.70 | AZZ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.56% | 0.24% | +0.32 | AZZ | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.48 | 4.50 | -0.02 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.1 | 62.9 | -15.81 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 12.1x | 36.3x | -24.20 | AZZ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.13B | $262.22B | -$258.09B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AZZ REV | TMO REV | AZZ GROSS % | TMO GROSS % | AZZ FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.65B | $44.56B | 23.9% | — | $444.7M | $6.29B |
| FY 2024 | $1.58B | $42.88B | 24.3% | — | $134.0M | $7.27B |
| FY 2023 | $1.54B | $42.86B | — | — | $244.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AZZ // BETA —
TMO // BETA 0.94